Seer is a pioneering company in the field of proteomics, aiming to revolutionize the way researchers explore the proteome. Through its flagship Proteograph Product Suite, Seer enables deep, unbiased, and rapid proteomics at scale, allowing scientists to analyze complex proteins and peptides with unprecedented coverage and throughput. The company's mission is to eliminate technological barriers in proteomics, advancing it at a pace comparable to genomics and transcriptomics, thus fostering exceptional scientific outcomes and improving human health. Seer provides comprehensive support and resources including training, webinars, and a vast catalog of multi-species proteins to assist researchers in unlocking the secrets of the proteome. The company also collaborates with global service partners and maintains active investor and community engagement.